{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T02:45:11Z","timestamp":1785293111507,"version":"3.55.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition Research"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.nutres.2025.05.006","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T16:06:31Z","timestamp":1747843591000},"page":"113-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Cathelicidin expression in the pathogenesis of atopic dermatitis and the therapeutic potential of vitamin D"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6006-9790","authenticated-orcid":false,"given":"Tess","family":"Connell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Seidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Neil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nutres.2025.05.006_bib0001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000370220","article-title":"Atopic dermatitis: global epidemiology and risk factors","volume":"66","author":"Nutten","year":"2015","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.nutres.2025.05.006_bib0002","first-page":"216","article-title":"Pruritus and pain constitute the main negative impact of atopic dermatitis from the patient\u2019s perspective: a systematic review","volume":"35","author":"Armario-Hita","year":"2023","journal-title":"Dermatology"},{"key":"10.1016\/j.nutres.2025.05.006_bib0003","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjd.19580","article-title":"The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990\u20132017","volume":"184","author":"Laughter","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0004","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/bjd.18643","article-title":"The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group","volume":"182","author":"Alexander","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.567090","article-title":"Colonization with Staphylococcus aureus in atopic dermatitis patients: attempts to reveal the unknown","volume":"11","author":"Ogonowska","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0006","doi-asserted-by":"crossref","first-page":"adv9413","DOI":"10.2340\/actadv.v103.9413","article-title":"Antimicrobial peptide loss, except for LL-37, is not characteristic of atopic dermatitis","volume":"103","author":"Szab\u00f3","year":"2023","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0007","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.3390\/ijms21207607","article-title":"Role of antimicrobial peptides in skin barrier repair in individuals with atopic dermatitis","volume":"21","author":"Nguyen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nutres.2025.05.006_bib0008","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4168\/aair.2013.5.3.119","article-title":"Vitamin D, the cutaneous barrier, antimicrobial peptides and allergies: is there a link?","volume":"5","author":"Roider","year":"2013","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.nutres.2025.05.006_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252762","article-title":"Impact of vitamin D status and cathelicidin antimicrobial peptide on adults with active pulmonary TB globally: a systematic review and meta-analysis","volume":"16","author":"Acen","year":"2021","journal-title":"PLOS One"},{"key":"10.1016\/j.nutres.2025.05.006_bib0010","first-page":"155","article-title":"The role of vitamin D in atopic dermatitis","volume":"26","author":"D\u0119bi\u0144ska","year":"2015","journal-title":"Dermatology"},{"key":"10.1016\/j.nutres.2025.05.006_bib0011","unstructured":"National Institute for Health and Care Excellence. Atopic eczema in under 12s: diagnosis and management. NICE clinical guidelines, No. 57, https:\/\/www.nice.org.uk\/guidance\/cg57\/resources [accessed 1 August 2023]."},{"key":"10.1016\/j.nutres.2025.05.006_bib0012","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1365-2133.2011.10449.x","article-title":"Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency","volume":"165","author":"Aubert-Wastiaux","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0013","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nutres.2025.05.006_bib0014","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.nutres.2025.05.006_bib0015","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1159\/000362789","article-title":"The human cathelicidin LL-37 host defense peptide upregulates tight junction-related proteins and increases human epidermal keratinocyte barrier function","volume":"6","author":"Akiyama","year":"2014","journal-title":"J Innate Immun"},{"key":"10.1016\/j.nutres.2025.05.006_bib0016","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jid.2022.10.020","article-title":"Cathelicidin LL-37 activates human keratinocyte autophagy through the P2\u00d77, mechanistic target of rapamycin, and MAPK pathways","volume":"143","author":"Ikutama","year":"2023","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0017","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.jid.5701099","article-title":"Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers","volume":"128","author":"Aberg","year":"2008","journal-title":"J Investig Dermatol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0018","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1523-1747.2003.12069.x","article-title":"The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium","volume":"120","author":"Heilborn","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0019","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1600-0625.2009.01030.x","article-title":"Differential expression of antimicrobial peptides in margins of chronic wounds","volume":"19","author":"Dressel","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0020","doi-asserted-by":"crossref","first-page":"11635","DOI":"10.1074\/jbc.M116.725317","article-title":"Non-coding double-stranded RNA and antimicrobial peptide LL-37 induce growth factor expression from keratinocytes and endothelial cells","volume":"291","author":"Adase","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nutres.2025.05.006_bib0021","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1089\/hum.2021.034","article-title":"Nonviral expression of LL-37 in a human skin equivalent to prevent infection in skin wounds","volume":"32","author":"Pati\u00f1o","year":"2021","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.nutres.2025.05.006_bib0022","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3390\/antibiotics10101210","article-title":"Efficacy of cathelicidin LL-37 in an MRSA wound infection mouse model","volume":"10","author":"Simonetti","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.nutres.2025.05.006_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105552","article-title":"A mouse model for vitamin D-induced human cathelicidin antimicrobial peptide gene expression","volume":"198","author":"Lowry","year":"2020","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0024","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jdermsci.2005.03.014","article-title":"Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli","volume":"40","author":"Chen","year":"2005","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.nutres.2025.05.006_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.105368","article-title":"Efficacy of antimicrobial peptide LL-37 against biofilm forming Staphylococcus aureus strains obtained from chronic wound infections","volume":"162","author":"Demirci","year":"2022","journal-title":"Microb Pathog"},{"key":"10.1016\/j.nutres.2025.05.006_bib0026","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/jid.2014.176","article-title":"Decreased susceptibility of Staphylococcus aureus small-colony variants toward human antimicrobial peptides","volume":"134","author":"Gl\u00e4ser","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0027","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1111\/all.14992","article-title":"Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis","volume":"76","author":"Kopfnagel","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.nutres.2025.05.006_bib0028","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1128\/IAI.71.7.3730-3739.2003","article-title":"Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes","volume":"71","author":"Midorikawa","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.nutres.2025.05.006_bib0029","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2567.2006.02399.x","article-title":"Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli","volume":"118","author":"Schauber","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.nutres.2025.05.006_bib0030","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMoa021481","article-title":"Endogenous antimicrobial peptides and skin infections in atopic dermatitis","volume":"347","author":"Ong","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nutres.2025.05.006_bib0031","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1128\/IAI.73.10.6771-6781.2005","article-title":"Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens","volume":"73","author":"Braff","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.nutres.2025.05.006_bib0032","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1471-2180-11-114","article-title":"Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus","volume":"11","author":"Dean","year":"2011","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2019.101584","article-title":"Cetik YS. Presence of biofilm and adhesin genes in Staphylococcus aureus strains taken from chronic wound infections and their genotypic and phenotypic antimicrobial sensitivity patterns","volume":"29","author":"Demir","year":"2020","journal-title":"Photodiagn Photodyn Ther"},{"key":"10.1016\/j.nutres.2025.05.006_bib0034","doi-asserted-by":"crossref","first-page":"8689","DOI":"10.1038\/s41598-017-08046-2","article-title":"Identification of bacterial biofilm and the Staphylococcus aureus derived protease, staphopain, on the skin surface of patients with atopic dermatitis","volume":"7","author":"Sonesson","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.nutres.2025.05.006_bib0035","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1398-9995.2011.02755.x","article-title":"The role of vitamin D in the immunopathogenesis of allergic skin diseases","volume":"67","author":"Benson","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.nutres.2025.05.006_bib0036","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1586\/1744666X.2013.816493","article-title":"Role of vitamin D in the pathogenesis and treatment of atopic dermatitis","volume":"9","author":"Borzutzky","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0037","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/257879","article-title":"Vitamin D and atopic dermatitis in childhood","volume":"2015","author":"Vestita","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.nutres.2025.05.006_bib0038","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaci.2008.03.027","article-title":"Antimicrobial peptides and the skin immune defense system","volume":"122","author":"Schauber","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0039","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/mnfr.201000174","article-title":"A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency","volume":"55","author":"Schwalfenberg","year":"2011","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.nutres.2025.05.006_bib0040","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/j.jid.2016.05.127","article-title":"Staphylococcus aureus exploits epidermal barrier defects in atopic dermatitis to trigger cytokine expression","volume":"136","author":"Nakatsuji","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.931717","article-title":"A systematic review of the (un)known host immune response biomarkers for predicting recurrence of urinary tract infection","volume":"9","author":"Sori\u0107 Hosman","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.nutres.2025.05.006_bib0042","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1600-0625.2009.00918.x","article-title":"Injury downregulates the expression of the human cathelicidin protein hCAP18\/LL-37 in atopic dermatitis","volume":"19","author":"Mallbris","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0043","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1398-9995.2012.02824.x","article-title":"Decreased serum LL-37 and vitamin D3 levels in atopic dermatitis: relationship between IL-31 and oncostatin M","volume":"67","author":"Kanda","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.nutres.2025.05.006_bib0044","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5021\/ad.2015.27.1.10","article-title":"Vitamin D status and its association with the SCORAD score and serum LL-37 level in Korean adults and children with atopic dermatitis","volume":"27","author":"Han","year":"2015","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0045","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaci.2008.08.020","article-title":"Administration of oral vitamin D induces cathelicidin production in atopic individuals","volume":"122","author":"Hata","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0046","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.jaci.2016.05.039","article-title":"Vitamin D and antimicrobial peptide levels in patients with atopic dermatitis and atopic dermatitis complicated by eczema herpeticum: a pilot study","volume":"138","author":"Albenali","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0047","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00403-022-02416-1","article-title":"Oral vitamin D modulates the epidermal expression of the vitamin D receptor and cathelicidin in children with atopic dermatitis","volume":"315","author":"Cabal\u00edn","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.nutres.2025.05.006_bib0048","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/jdv.12176","article-title":"A randomized controlled double-blind investigation of the effects of vitamin D dietary supplementation in subjects with atopic dermatitis","volume":"28","author":"Hata","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0049","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000485132","article-title":"Vitamin D and the pathophysiology of inflammatory skin diseases","volume":"31","author":"Umar","year":"2018","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0050","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00403-010-1045-4","article-title":"Control of cutaneous antimicrobial peptides by vitamin D3","volume":"302","author":"Dombrowski","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.nutres.2025.05.006_bib0051","first-page":"S23","article-title":"The effects of oral vitamin D supplement on atopic dermatitis: a clinical trial with Staphylococcus aureus colonization determination","volume":"98","author":"Udompataikul","year":"2015","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.nutres.2025.05.006_bib0052","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3109\/00365541003602049","article-title":"Vitamin D and methicillin-resistant Staphylococcus aureus nasal carriage","volume":"42","author":"Matheson","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.nutres.2025.05.006_bib0053","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/1469-0691.12350","article-title":"Effect of vitamin D3 supplementation on Staphylococcus aureus nasal carriage: a randomized, double-blind, placebo-controlled trial in healthy adults","volume":"20","author":"Slow","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.nutres.2025.05.006_bib0054","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jaad.2013.03.014","article-title":"Vitamin D effects in atopic dermatitis","volume":"69","author":"Samochocki","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0055","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/INF.0000000000000667","article-title":"Vitamin D sufficiency and Staphylococcus aureus infection in children","volume":"34","author":"Wang","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.nutres.2025.05.006_bib0056","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1398-9995.2011.02719.x","article-title":"EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference","volume":"67","author":"Schram","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.nutres.2025.05.006_bib0057","article-title":"Vitamin D deficiency and effects of vitamin D supplementation on disease severity in patients with atopic dermatitis: a systematic review and meta-analysis in adults and children","volume":"11","author":"Hattangdi-Haridas","year":"2019","journal-title":"Nutrition"},{"key":"10.1016\/j.nutres.2025.05.006_bib0058","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9407888","article-title":"Serum vitamin D level and efficacy of vitamin D supplementation in children with atopic dermatitis: a systematic review and meta-analysis","volume":"2022","author":"Fu","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"10.1016\/j.nutres.2025.05.006_bib0059","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.nut.2016.01.023","article-title":"Vitamin D and atopic dermatitis: a systematic review and meta-analysis","volume":"32","author":"Kim","year":"2016","journal-title":"Nutrition"},{"key":"10.1016\/j.nutres.2025.05.006_bib0060","article-title":"Vitamin D status and efficacy of vitamin D supplementation in atopic dermatitis: a systematic review and meta-analysis","volume":"8","author":"Kim","year":"2016","journal-title":"Nutrition"},{"key":"10.1016\/j.nutres.2025.05.006_bib0061","first-page":"327","article-title":"Vitamin D supplementation in the treatment of atopic dermatitis: a clinical trial study","volume":"11","author":"Amestejani","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0062","first-page":"41","article-title":"Serum vitamin D levels and vitamin D supplementation do not correlate with the severity of chronic eczema in children","volume":"47","author":"Galli","year":"2015","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0063","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.679","article-title":"The impact of vitamin D supplementation as an adjuvant therapy on clinical outcomes in patients with severe atopic dermatitis: a randomized controlled trial","volume":"8","author":"Mansour","year":"2020","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.nutres.2025.05.006_bib0064","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/ijd.14220","article-title":"Oral vitamin D3 5000 IU\/day as an adjuvant in the treatment of atopic dermatitis: a randomized control trial","volume":"57","author":"S\u00e1nchez-Armend\u00e1riz","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0065","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jaci.2014.08.002","article-title":"Randomized trial of vitamin D supplementation for winter-related atopic dermatitis in children","volume":"134","author":"Camargo","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0066","doi-asserted-by":"crossref","first-page":"66","DOI":"10.15586\/aei.v49i2.67","article-title":"Vitamin D supplementation and severity of atopic dermatitis: pre-post assessment","volume":"49","author":"Imoto","year":"2021","journal-title":"Allergol Immunopathol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0067","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1600-0625.2008.00768.x","article-title":"The vitamin D pathway: a new target for control of the skin\u2019s immune response?","volume":"17","author":"Schauber","year":"2008","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.nutres.2025.05.006_bib0068","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.iac.2010.05.005","article-title":"Vitamin D in atopic dermatitis, asthma and allergic diseases","volume":"30","author":"Searing","year":"2010","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.nutres.2025.05.006_bib0069","article-title":"Scientific opinion on the tolerable upper intake level for vitamin D, including the derivation of a conversion factor for calcidiol monohydrate","volume":"21","author":"Turck","year":"2023","journal-title":"EFSA J"},{"key":"10.1016\/j.nutres.2025.05.006_bib0070","article-title":"Vitamin D receptor (VDR) gene polymorphisms modify the response to vitamin D supplementation: a systematic review and meta-analysis","volume":"14","author":"Usategui-Mart\u00edn","year":"2022","journal-title":"Nutrition"}],"container-title":["Nutrition Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0271531725000752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0271531725000752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T15:00:40Z","timestamp":1750777240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0271531725000752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":70,"alternative-id":["S0271531725000752"],"URL":"https:\/\/doi.org\/10.1016\/j.nutres.2025.05.006","relation":{},"ISSN":["0271-5317"],"issn-type":[{"value":"0271-5317","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cathelicidin expression in the pathogenesis of atopic dermatitis and the therapeutic potential of vitamin D","name":"articletitle","label":"Article Title"},{"value":"Nutrition Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nutres.2025.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}